DMR reduces post-tirzepatide weight regain by 40% in REMAIN-1 trial
Updated
Updated · Medscape · Apr 24
DMR reduces post-tirzepatide weight regain by 40% in REMAIN-1 trial
12 articles · Updated · Medscape · Apr 24
Six-month interim results from the multicenter REMAIN-1 trial show patients receiving duodenal mucosal resurfacing regained about 7 lbs, 40% less than the sham group, after stopping tirzepatide.
The minimally invasive DMR procedure was safe, with no serious complications, and helped participants maintain over 80% of their pre-discontinuation weight loss, addressing a major challenge for those discontinuing GLP-1 drugs.
With 70% of GLP-1 users typically regaining weight post-therapy, DMR could offer a significant new option for long-term weight maintenance, pending further results on durability and optimization of the procedure.
How does this new gut procedure impact cravings and other metabolic markers?
Will insurers cover a one-time procedure over years of expensive weight-loss drugs?
Is a 'metabolic reset' a better solution than simply taking less medication?
If approved by the FDA, when could this procedure become widely available?
What are the hidden long-term risks of permanently altering the small intestine?
Breakthrough Duodenal Mucosal Resurfacing Cuts Post-GLP-1 Weight Regain by 40%
Overview
At DDW 2026, the REMAIN-1 trial revealed that duodenal mucosal resurfacing (DMR), a minimally invasive procedure, reduces weight regain by 40% six months after stopping GLP-1 medications, which often see high discontinuation rates due to cost and side effects. DMR works by removing damaged duodenal lining caused by unhealthy diets, allowing regeneration that restores natural hormone production, improving insulin sensitivity and metabolic health. The procedure is safe, with quick recovery, and targets patients who lost significant weight on GLP-1 drugs. With full trial data and FDA submission expected in late 2026, DMR could become a durable, cost-effective strategy to sustain weight loss and reduce lifelong medication dependence.